Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at email@example.com if you need assistance.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
Our new book is a comprehensive look at a vital part of medicines development and regulatory affairs. Grab your copy today!
Hear from leaders around the globe as they share insights about their experiences and lessons learned throughout their certification journey.
| 19 September 2013 | By Ansis Helmanis,
China's Food and Drug Administration (CFDA) is requiring clinical trial sponsors to register all trials (Phases I, II, III, IV) and bioequivalence testing, according to World Health Organization (WHO) requirements posted online.
The 6 September 2013 bulletin mandates that the required information be posted within one month after pre-registration of the trial, followed by an update within one year.
The trial's approval will be revoked if the registration requirements are not complied with within three years. For approved drugs, the registration must be completed within three months of the date of the notice.
The website will be managed by CFDA's Center for Drug Evaluation.
CFDA Clinical Trial Registration Requirements
Read all Breaking News from RegLink
Tags: Transparency, Latest News, clinical trial, registration